This site is intended for healthcare professionals

WHO Solidarity trial and WHO recommendations find no evidence to support remdesivir and other re-purposed drugs to improve COVID-19 outcomes.

Read time: 1 mins
Last updated:27th Nov 2020
Published:27th Nov 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register for free exclusive healthcare eLearning resources

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest